# Intest Corp: overview

INTT · NYSE · CIK 1036262 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/intt.md) · [Financials](/companies/intt/financials.md) · [Filings](/companies/intt/filings.md) · [Insiders](/companies/intt/insiders.md)

Latest reported revenue: [$33.9m](/filings/0001036262-26-000032.md) for Q1 FY2026, three months to 2026-03-31, from the 10-Q filed May 11, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001036262-26-000032).

## Last eight quarters

| Line item | Unit | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [34.0](/filings/0001036262-25-000023.md) | [30.3](/filings/0001036262-25-000029.md) | [36.6](/filings/0001437749-25-007520.md) | [26.6](/filings/0001036262-26-000032.md) | [28.1](/filings/0001036262-25-000023.md) | [26.2](/filings/0001036262-25-000029.md) | [32.8 d](/filings/0001036262-26-000012.md) | [33.9](/filings/0001036262-26-000032.md) |
| Gross margin | % | [40.6%](/filings/0001036262-25-000023.md) | [46.3%](/filings/0001036262-25-000029.md) | [39.7%](/filings/0001437749-25-007520.md) | [41.5%](/filings/0001036262-26-000032.md) | [42.6%](/filings/0001036262-25-000023.md) | [41.9%](/filings/0001036262-25-000029.md) | [45.4% d](/filings/0001036262-26-000012.md) | [45.5%](/filings/0001036262-26-000032.md) |
| Operating margin | % | [1.0%](/filings/0001036262-25-000023.md) | [1.6%](/filings/0001036262-25-000029.md) | [5.7% d](/filings/0001036262-26-000012.md) | [(10.8%)](/filings/0001036262-26-000032.md) | [(3.3%)](/filings/0001036262-25-000023.md) | [(4.5%)](/filings/0001036262-25-000029.md) | [3.9% d](/filings/0001036262-26-000012.md) | [2.8%](/filings/0001036262-26-000032.md) |
| Net margin | % | [0.7%](/filings/0001036262-25-000023.md) | [1.6%](/filings/0001036262-25-000029.md) | [4.1%](/filings/0001437749-25-007520.md) | [(8.7%)](/filings/0001036262-26-000032.md) | [(1.8%)](/filings/0001036262-25-000023.md) | [(3.6%)](/filings/0001036262-25-000029.md) | [3.8% d](/filings/0001036262-26-000012.md) | [2.3%](/filings/0001036262-26-000032.md) |
| Diluted EPS | $ per share | [0.02](/filings/0001036262-25-000023.md) | [0.04](/filings/0001036262-25-000029.md) | [0.12](/filings/0001437749-25-007520.md) | [(0.19)](/filings/0001036262-26-000032.md) | [(0.04)](/filings/0001036262-25-000023.md) | [(0.08)](/filings/0001036262-25-000029.md) | not reported | [0.06](/filings/0001036262-26-000032.md) |
| Free cash flow | $m | [(5.4) d](/filings/0001036262-25-000023.md) | [3.7 d](/filings/0001036262-25-000029.md) | [2.4 d](/filings/0001036262-26-000012.md) | [5.3](/filings/0001036262-26-000032.md) | [(1.2) d](/filings/0001036262-25-000023.md) | [3.1 d](/filings/0001036262-25-000029.md) | [(1.6) d](/filings/0001036262-26-000012.md) | [(4.0)](/filings/0001036262-26-000032.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [84.9](/filings/0001437749-23-007539.md) | [117](/filings/0001437749-24-009626.md) | [123](/filings/0001437749-25-007520.md) | [131](/filings/0001036262-26-000012.md) | [114](/filings/0001036262-26-000012.md) |
| Gross margin | % | [48.6%](/filings/0001437749-23-007539.md) | [45.7%](/filings/0001437749-24-009626.md) | [46.2%](/filings/0001437749-25-007520.md) | [42.4%](/filings/0001036262-26-000012.md) | [43.0%](/filings/0001036262-26-000012.md) |
| Operating margin | % | [10.0%](/filings/0001437749-23-007539.md) | [9.2%](/filings/0001437749-24-009626.md) | [8.5%](/filings/0001437749-25-007520.md) | [2.6%](/filings/0001036262-26-000012.md) | [(3.3%)](/filings/0001036262-26-000012.md) |
| Net margin | % | [8.6%](/filings/0001437749-23-007539.md) | [7.2%](/filings/0001437749-24-009626.md) | [7.6%](/filings/0001437749-25-007520.md) | [2.2%](/filings/0001036262-26-000012.md) | [(2.2%)](/filings/0001036262-26-000012.md) |
| Diluted EPS | $ per share | [0.68](/filings/0001437749-23-007539.md) | [0.78](/filings/0001437749-24-009626.md) | [0.79](/filings/0001437749-25-007520.md) | [0.24](/filings/0001036262-26-000012.md) | [(0.21)](/filings/0001036262-26-000012.md) |
| Free cash flow | $m | [9.8](/filings/0001437749-23-007539.md) | [(2.8)](/filings/0001437749-24-009626.md) | [14.9](/filings/0001437749-25-007520.md) | [2.5](/filings/0001036262-26-000012.md) | [5.7](/filings/0001036262-26-000012.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/intt/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $24.5m | 1,349,896 |  | Reduced −82,000 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $17.0m | 936,047 |  | Added +662,100 |
| [First Eagle Investment Management, LLC](/funds/1325447.md) | 2026-06-30 | $11.1m | 612,602 |  | Added +188,500 |
| [First Eagle Investment Management, LLC](/funds/1325447.md) | 2026-06-30 | $11.1m | 612,602 |  | Added +188,500 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $9.3m | 510,105 |  | Reduced −95,421 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $9.1m | 502,237 |  | Added +52,028 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $8.0m | 440,213 |  | Reduced −26,184 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $5.2m | 285,517 |  | Added +248,087 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $5.1m | 282,935 |  | Added +154,495 |
| [Pacific Ridge Capital Partners, LLC](/funds/1591546.md) | 2026-06-30 | $4.5m | 248,275 |  | Reduced −254,024 |

## Recent filings

[All 716 filings](/companies/intt/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-05 | 12:39 ET | [8-K](/filings/0001036262-26-000057.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001036262-26-000057 |
| 2026-08-17 | 20:04 ET | [8-K](/filings/0001036262-26-000047.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001036262-26-000047 |
| 2026-08-10 | 20:08 ET | [10-Q](/filings/0001036262-26-000045.md) | Quarterly report, period 2026-06-30 | 0001036262-26-000045 |
| 2026-08-10 | 11:52 ET | [8-K](/filings/0001036262-26-000042.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001036262-26-000042 |
| 2026-07-31 | 12:32 ET | [8-K](/filings/0001036262-26-000040.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001036262-26-000040 |
| 2026-06-18 | 20:26 ET | [8-K](/filings/0001036262-26-000036.md) | 5.07 Shareholder vote results | 0001036262-26-000036 |
| 2026-05-11 | 20:12 ET | [10-Q](/filings/0001036262-26-000032.md) | Quarterly report, period 2026-03-31 | 0001036262-26-000032 |
| 2026-05-05 | 10:24 ET | [8-K](/filings/0001036262-26-000029.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001036262-26-000029 |
| 2026-04-28 | 20:03 ET | [DEF 14A](/filings/0001036262-26-000024.md) | Proxy statement, period 2026-06-17 | 0001036262-26-000024 |
| 2026-04-10 | 20:15 ET | [8-K](/filings/0001036262-26-000016.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001036262-26-000016 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001036262-26-000012.md), filed Mar 12, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1036262
- Tickers: INTT
- Exchange: NYSE
- SIC code: 3825 Instruments For Meas & Testing of  Electricity & Elec Signals
- State of incorporation: DE
- Filer category: Accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.
